« FDA approves device to maintain blood flow during artery bypass | Main | FDA Approvals - FDA Proposes Draft Menu And Vending Machine Labeling Requirements, Invites »

FDA approves imaging agent for central nervous system scans The


FDA approves imaging agent for central nervous system scans
The U.S. Food and Drug Administration today approved Gadavist (gadobutrol), a gadolinium-based contrast agent, for use in patients undergoing magnetic resonance imaging (MRI) of the central nervous system.
 

©2006 FDA-News.com. All rights reserved.